SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-057907
Filing Date
2011-10-14
Accepted
2011-10-14 16:47:54
Documents
7
Period of Report
2011-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v237236_10k.htm 10-K 8479938
2 EXHIBIT 21 v237236_ex21.htm EX-21 12622
3 EXHIBIT 23 v237236_ex23.htm EX-23 3908
4 EXHIBIT 31.1 v237236_ex31-1.htm EX-31.1 15240
5 EXHIBIT 31.2 v237236_ex31-2.htm EX-31.2 14637
6 EXHIBIT 32 v237236_ex32.htm EX-32 7332
7 GRAPHIC pg32.jpg GRAPHIC 62737
  Complete submission text file 0001144204-11-057907.txt   8621280
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 111142262
SIC: 2834 Pharmaceutical Preparations